Atopic Dermatitis in US Adults: From Population to Health Care Utilization.

[1]  D. Margolis,et al.  Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. , 2019, The Journal of investigative dermatology.

[2]  D. Margolis,et al.  Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  J. Silverberg,et al.  Financial burden of emergency department visits for atopic dermatitis in the United States , 2018, Journal of the American Academy of Dermatology.

[4]  J. Silverberg,et al.  Atopic dermatitis in US adults: Epidemiology, association with marital status, and atopy. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[5]  D. Margolis,et al.  Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. , 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  J. Silverberg,et al.  Validation of patient‐reported global severity of atopic dermatitis in adults , 2018, Allergy.

[7]  D. Margolis,et al.  Racial and ethnic differences in health care utilization for childhood eczema: An analysis of the 2001‐2013 Medical Expenditure Panel Surveys , 2017, Journal of the American Academy of Dermatology.

[8]  J. Silverberg,et al.  Inpatient Financial Burden of Atopic Dermatitis in the United States. , 2017, The Journal of investigative dermatology.

[9]  C. Flohr,et al.  Measurement properties of quality‐of‐life measurement instruments for infants, children and adolescents with eczema: a systematic review , 2017, The British journal of dermatology.

[10]  H. Williams,et al.  Patient‐Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement , 2017, The British journal of dermatology.

[11]  C. Terwee,et al.  Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review , 2017, Allergy.

[12]  Mohannad A. Awad,et al.  Pubic Hair Grooming Prevalence and Motivation Among Women in the United States. , 2016, JAMA dermatology.

[13]  P. Spuls,et al.  Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review , 2016, The British journal of dermatology.

[14]  J. Silverberg,et al.  Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. , 2016, Journal of the American Academy of Dermatology.

[15]  H. Williams,et al.  Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative) , 2016, The British journal of dermatology.

[16]  C. Apfelbacher,et al.  Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review. , 2016, Acta dermato-venereologica.

[17]  J. Schmitt,et al.  Measurement properties of adult quality‐of‐life measurement instruments for eczema: a systematic review , 2016, Allergy.

[18]  Honghu Liu,et al.  Use of Internet panels to conduct surveys , 2015, Behavior research methods.

[19]  J. Schmitt,et al.  Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME) , 2014, The British journal of dermatology.

[20]  J. Stalder,et al.  Analysis of Correlations between Patient-Oriented SCORAD (PO-SCORAD) and Other Assessment Scores of Atopic Dermatitis Severity and Quality of Life , 2014, Dermatology.

[21]  D. Margolis,et al.  Persistence of mild to moderate atopic dermatitis. , 2014, JAMA dermatology.

[22]  J. Ravenscroft,et al.  Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods , 2013, The British journal of dermatology.

[23]  D. Kashy,et al.  Correspondence and correlates of couples' skin cancer screening. , 2013, JAMA dermatology.

[24]  Suephy C. Chen,et al.  Clinical meaning in skin-specific quality of life instruments: a comparison of the Dermatology Life Quality Index and Skindex banding systems. , 2012, Dermatologic clinics.

[25]  T Reunala,et al.  Patient‐Oriented SCORAD (PO‐SCORAD): a new self‐assessment scale in atopic dermatitis validated in Europe , 2011, Allergy.

[26]  H. Williams,et al.  Harmonising Outcome Measures for Eczema (HOME).Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany , 2010, The British journal of dermatology.

[27]  H. Wulf,et al.  Life quality assessment among patients with atopic eczema , 2006, The British journal of dermatology.

[28]  G. Jemec,et al.  Does visible atopic dermatitis affect quality of life more in women than in men? , 2004, Gender medicine.

[29]  Raj Jobanputra,et al.  The effect of skin diseases on quality of life in patients from different social and ethnic groups in Cape Town, South Africa , 2000, International journal of dermatology.

[30]  X. Badia,et al.  Measuring health‐related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI , 1999, The British journal of dermatology.

[31]  D. Ruta,et al.  Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods , 1997, The British journal of dermatology.

[32]  L. Baker,et al.  Excess cost of emergency department visits for nonurgent care. , 1994, Health affairs.

[33]  R. Hay,et al.  The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation , 1994, The British journal of dermatology.

[34]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[35]  J. Silverberg,et al.  Predictors of Hospitalization, Length of Stay, and Costs of Care Among Adult and Pediatric Inpatients With Atopic Dermatitis in the United States , 2018, Dermatitis : contact, atopic, occupational, drug.

[36]  D. Meads,et al.  Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? , 2012, The Journal of investigative dermatology.